Cite
MLA Citation
et al.. “Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial.” Lancet, vol. 4, 2022, pp. e24–e32. http://access.bl.uk/ark:/81055/vdc_100148069872.0x000001